Nymox Pharmaceutical (NYMXF) Return on Assets [ROA] (2018 - 2024)
Nymox Pharmaceutical (NYMXF) recorded Return on Assets [ROA] of -695.12% in FY2025, up 6.21 percentage points from -701.33% in FY2024.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Return on Assets [ROA] (2018 - 2024) Analysis & Trends
Starting with FY2016, Nymox Pharmaceutical's Return on Assets [ROA] history includes 10 years.
- Annual Return on Assets [ROA] has a five-year change of -456.35 percentage points (FY2020 to FY2025).
- The FY2025 figure is the highest annual Return on Assets [ROA] since FY2022.
- Per Business Quant data, NYMXF's Return on Assets [ROA] was -701.33% in FY2024 (+84.11 pp), -785.44% in FY2023 (-356.75 pp), -428.68% in FY2022 (+4.67 pp) and -433.36% in FY2021 (-194.59 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.14% |
| 10 | Nymox Pharmaceutical | 6.12 Mn | 5.93 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1,239.44% |
| Sep 30, 2024 | -1,306.63% |
| Dec 31, 2023 | -1,364.81% |
| Sep 30, 2023 | -1,036.60% |
| Jun 30, 2023 | -1,259.34% |
| Mar 31, 2023 | -261.55% |
| Dec 31, 2022 | -275.95% |
| Sep 30, 2022 | -211.35% |
| Jun 30, 2022 | -345.03% |
| Mar 31, 2022 | -1,132.71% |
| Dec 31, 2021 | -473.63% |
| Sep 30, 2021 | -223.44% |
| Jun 30, 2021 | -310.45% |
| Mar 31, 2021 | -398.83% |
| Dec 31, 2020 | -232.83% |
| Sep 30, 2020 | -364.92% |
| Jun 30, 2020 | -483.64% |
| Mar 31, 2020 | -291.35% |
| Dec 31, 2019 | -203.26% |
| Sep 30, 2019 | -155.45% |
API Access
Nymox Pharmaceutical Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();